Literature DB >> 15952985

Chromosomal changes in prostate cancer: a fluorescence in situ hybridization study.

K Das1, W Lau, Cr Sivaswaren, Tan Ph, Smc Fook-Chong, Tien Sl, C Cheng.   

Abstract

The incidence of prostate cancer (PC) is increasing steadily with the aging population in Singapore. As the pattern of chromosomal aberrations in Asian men with PC is poorly understood, we investigated the numerical aberrations for chromosomes 7, 8, 11, and 17 by fluorescence in situ hybridization (FISH). FISH was performed on standard sections and tissue microarrays of 54 PC and 33 benign prostatic hyperplasia (BPH) specimens. Among the 54 PC specimens, FISH detected 44 cases as aneusomy and two as disomy and was unsuccessful for eight cases. Cytogenetic alterations of two or more chromosomes per tumor were detected in 33/46 (72%) PCs. The most frequent alteration was aneusomy of chromosome 8 detected in 34/46 (74%) cases followed by numerical aberrations in chromosome 7 (61%). Gain of 8q24, loss of chromosome 7, and gain of 11q13 were associated with higher Gleason score and were statistically significant. Gain of chromosome 7 was more common in locally advanced disease, while gain of chromosome 11q13 and chromosome 7 was more common in metastatic disease.

Entities:  

Mesh:

Year:  2005        PMID: 15952985     DOI: 10.1111/j.1399-0004.2005.00452.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men.

Authors:  Joke Beuten; Jonathan A L Gelfond; Margarita L Martinez-Fierro; Korri S Weldon; AnaLisa C Crandall; Augusto Rojas-Martinez; Ian M Thompson; Robin J Leach
Journal:  Carcinogenesis       Date:  2009-06-15       Impact factor: 4.944

2.  Deletion of 8p is an independent prognostic parameter in prostate cancer.

Authors:  Martina Kluth; Nina Nadine Amschler; Rami Galal; Christina Möller-Koop; Phillipp Barrow; Maria Christina Tsourlakis; Frank Jacobsen; Andrea Hinsch; Corinna Wittmer; Stefan Steurer; Till Krech; Franziska Büscheck; Till Sebastian Clauditz; Burkhard Beyer; Waldemar Wilczak; Markus Graefen; Hartwig Huland; Sarah Minner; Thorsten Schlomm; Guido Sauter; Ronald Simon
Journal:  Oncotarget       Date:  2017-01-03

Review 3.  Improving adenoviral vectors and strategies for prostate cancer gene therapy.

Authors:  Rodrigo Esaki Tamura; Igor Vieira de Luna; Marlous Gomes Lana; Bryan E Strauss
Journal:  Clinics (Sao Paulo)       Date:  2018-08-20       Impact factor: 2.365

4.  Landscape of chromosome number changes in prostate cancer progression.

Authors:  Martin Braun; Julia Stomper; Robert Kirsten; David Adler; Wenzel Vogel; Diana Böhm; Nicolas Wernert; Glen Kristiansen; Sven Perner
Journal:  World J Urol       Date:  2013-03-20       Impact factor: 4.226

5.  Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors.

Authors:  Jia-Jie Hao; Zhi-Zhou Shi; Zhi-Xin Zhao; Yu Zhang; Ting Gong; Chun-Xiang Li; Ting Zhan; Yan Cai; Jin-Tang Dong; Song-Bin Fu; Qi-Min Zhan; Ming-Rong Wang
Journal:  BMC Cancer       Date:  2012-08-24       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.